At 3 year follow up, the CoreValve US Pivotal study on high risk elderly patients, the self-expanding valve showed a lasting benefit vs. surgery. These findings could suggest that the self-expanding valve should be considered the preferred treatment in patients with symptomatic severe aortic stenosis at increased risk for surgery. The study included 797 patients...
TAVR-LM Registry: Transcatheter Aortic Valve Replacement and Left Main Stenting
Original Title: Outcomes in Patients with Transcatheter Aortic Valve Replacement and Left Main Stenting. The TAVR-LM Registry. Reference: TarunChakravarty et al. Journal of the American College of Cardiology, Vol 67, N° 8, 2016. Courtesy of Dr. Santiago F. Coroleu. High surgical risk patients with severe aortic stenosis and significant left main aortic arterydiseaseare often treated combining...
One year outcomes of the new repositionable and retrievable valve
Original Title: 1-Year Outcomes with the Fully Repositionable and Retrievable Lotus Transcatheter Aortic Replacement Valve in 120 High-Risk Surgical Patients with Severe Aortic Stenosis Results of the REPRISE II Study. Reference: Ian T. Meredith et al. J Am Coll Cardiol Intv. 2016;9(4):376-384. This analysis represents the first report at one year of 120 patients enrolled...
Educational Journal N° 103
Edición Especial | Congreso SOLACI-SOCIME 2015, in partnership with TCT 1. Reparación endovascular de la patología de aorta torácica a) Tratando anatomías complejas con TEVAR y EVAR b) El valor de la imagen de la tomografía computada de alta resolución en el diagnóstico y detección de complicaciones en pacientes con síndrome aórtico agudo c) La...
Experiencia Inicial con el Implante Percutáneo de la Válvula Melody® en Brasil
Marcelo Silva Ribeiro, Carlos A.C. Pedra, Rodrigo N. Costa, Raul Ivo Rossi, João Luiz Manica, Wanda T.M. Nascimento, Luís Otávio Campanha, Valmir F. Fontes, Simone F. Pedra, Daniela L. Kreuzig, John P. Cheatham
Coste-efectividad Incremental del Tratamiento Quirúrgico frente al Percutáneo de la Persistencia del Canal Arterial con Amplatzer® Duct Occluder en Niños: Revisión sistemática
Rodrigo Nieckel da Costa, Marcelo Silva Ribeiro, André Ferreira da Silva, Rodrigo Antonini Ribeiro, Otávio Berwanger, Alexandre Biasi, Hélio Penna, Carisi Anne Polanczyk, Marcelo Queiroga, Carlos Augusto Cardoso Pedra
Artículo original: Implante por Catéter de Bioprótesis Valvular Aórtica para Tratamiento de Estenosis Valvar Aórtica Grave en Pacientes Inoperables desde la Perspectiva de la Salud Suplementaria
Marcelo Cartaxo Queiroga; Alvaro Mitsunori Nishikawa; Luciano Morganti Paladini; Pedro Alves Lemos Neto; Fabio Sândoli Brito Júnior; Rogério Sarmento-Leite; Christiane Bueno; Otávio Augusto C. Clark; J. Antonio Marin-Neto; J. Eduardo Sousa
Implante Transcatéter de Bioprótesis Valvular Pulmonar: Revisión Sistemática de la Literatura
Tobias Engel Ayer Botrel, Otávio Augusto C. Clark, Marcelo C. Queiroga, Raul I. Rossi Filho, Carlo B. Pilla, Raul S. Arrieta, Salvador Cristovão, Célia C. Silva, Cesar A. Esteves, Edmundo Clarindo Oliveira, Luiz Carlos Simões, Francisco Chamié, Julia
CoreValve Evolut R CE: Good results at 6 months of the new CoreValve repositionable
This study evaluated the safety and efficacy of the new repositionable self-expanding valve. The primary end point was all-cause mortality and stroke at 30 days. 60 patients were included and the possibility for reposition was used 22 times between 12 recaptures and 10 re-sheathed of the valve. All maneuvers were carried out successfully. A 30...
TAVR é um procedimento tão seguro e eficaz quanto a substituição cirúrgica num seguimento de dois anos em pacientes de menor risco.
Fundamentos e Objetivos: A substituição da válvula aórtica via transcateter (TAVR) é uma opção em determinados pacientes cirúrgicos de alto risco com estenose da válvula aórtica grave. Desconhecemos se a TAVR pode ser introduzida com segurança para os pacientes de baixo risco. O estudo NOTION (Nordic Aortic Valve Intervention Trial) é um ensaio clínico randomizado...